Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy
β Scribed by Udo Rudloff; Edi Brogi; Julia P. Brockway; Jessica I. Goldberg; Milicent Cranor; Christine A. Wynveen; Tatjana Nehhozina; Anne S. Reiner; Sujata Patil; Kimberly J. Van Zee
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 428 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The authors reviewed their institution's experience treating patients with mammographically detected ductal carcinoma in situ (DCIS) of the breast with breast-conserving therapy (BCT) to determine 10-year rates of local control and survival and to identify factors associated with local recurrence.
## Abstract ## BACKGROUND. Results from numerous trials have indicated that breastβconserving therapy (BCT) produces outcomes equivalent to those produced by mastectomy in terms of both locoregional control and survival. However, conservative treatment has resulted in the dilemma of how best to ad
## Background: When found in an otherwise benign biopsy, lobular carcinoma in situ (lcis) has been associated with an increased risk of development of a subsequent invasive breast carcinoma. however, the association between lcis and the risk of subsequent local recurrence in patients with infiltrat
## Abstract ## BACKGROUND The purpose of the current analysis was to evaluate the impact of local recurrence (LR) on the development of distant metastases (DM), overall survival (OS), and cause specific survival (CSS) in patients with earlyβstage breast carcinoma who underwent conservative surgery